Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL57588 | 1.00 | ALDH1A1 (0.52) | ALDH1A1NLRP3LMNAPOLBTP53 | |
| SCHEMBL78536 | 1.00 | ALDH1A1 (0.52) | ALDH1A1NLRP3LMNAPOLBTP53 | |
| Water SCHEMBL28213494 | 0.98 | ALDH1A1 (0.50) | ALDH1A1NLRP3LMNAPOLBTP53 | |
| SCHEMBL28191220 | 0.98 | ALDH1A1 (0.50) | ALDH1A1NLRP3LMNAPOLBTP53 | |
| Methane SCHEMBL6359900 | 0.98 | ALDH1A1 (0.50) | ALDH1A1NLRP3LMNAPOLBTP53 | |
| Bicarbonate SCHEMBL29739743 | 0.96 | ALDH1A1 (0.49) | ALDH1A1NLRP3MGLL | |
| Cyclohexane SCHEMBL6354277 | 0.96 | ALDH1A1 (0.49) | ALDH1A1NLRP3LMNAPOLBTP53 | |
| Benzene SCHEMBL28778902 | 0.94 | MGLL (0.54) | MGLL | |
| Glycidol SCHEMBL5673692 | 0.93 | ALDH1A1 (0.46) | ALDH1A1NLRP3LMNAPOLBTP53 | |
| SCHEMBL4214489 | 0.93 | ALDH1A1 (0.46) | ALDH1A1NLRP3LMNAPOLBTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 845 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118324996-A | Composition for gel electrolyte, electrochromic device and preparation method of electrochromic device | 比亚迪股份有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-115385959-B | High-purity tedizolid phosphate and preparation method thereof | 浙江尖峰药业有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-115825292-B | Method for detecting S-glycidol in glycidyl R-butyrate | 四川美域高生物医药科技有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-115873026-A | Tedizolid intermediate and preparation method of tedizole phosphate | 石药集团欧意药业有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-115873036-A | Synthetic method of tedizolid phosphate | 中国药科大学 | 2023-03-31 | — | — | CN | claimed |
| CN-115825292-A | Method for detecting S-glycidol in R-glycidyl butyrate | 四川美域高生物医药科技有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-115385959-A | High-purity tedizolid phosphate and preparation method thereof | 浙江尖峰药业有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-216826113-U | Feeding device for preparing (R) -glycidyl butyrate | 华今(山东)新材料科技有限公司 | 2022-06-28 | — | — | CN | claimed |
| CN-110804038-B | Preparation method of tedizolid phosphate and intermediate thereof | 上海博志研新药物技术有限公司 | 2021-03-05 | — | — | CN | claimed |
| CN-107286111-B | Preparation method of oxazolidinone compound | 广东赛法洛药业有限公司 | 2020-06-19 | — | — | CN | claimed |
| US-20100063117-A1 | Novel oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient | KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) | 2010-03-11 | — | — | US | claimed |
| WO-2009063505-A2 | PROCESS FOR PREPARATION OF (S) (N-[[3-[3-FLUORO-4-(4-MORPHOLINYL) HEN L -2-OXO-5-OXAZOLIDIN L METHYL]ACETAMIDE | USV LIMITED (IN) | 2009-05-22 | — | — | WO | claimed |
| WO-2005003087-A2 | OXAZOLE DERIVATIVES AS ANTIBACTERIAL AGENTS | ORCHID CHEMICALS AND PHARMACEUTICALS LTD. (IN) | 2005-01-13 | — | — | WO | claimed |
| WO-2004101552-A1 | OXAZOLIDINONE DERIVATIVES AS ANTIBACTERIAL AGENTS | ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) | 2004-11-25 | — | — | WO | claimed |
| WO-2004009587-A1 | OXAZOLIDINONE DERIVATIVES AS ANTIBACTERIAL AGENTS | ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) | 2004-01-29 | — | — | WO | claimed |
| WO-2003106454-A1 | 1H-ISOQUINOLINE-OXAZOLIDINONE DERIVATIES AND THEIR USE AS ANTIBACTERIAL AGENTS | ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) | 2003-12-24 | — | — | WO | claimed |
| US-6313307-B1 | DEBLOCKING, DEPROTECTING; CATALYTIC HYDROGENATION, ALKYLATION; PREPARING MICROBIOCIDES AGAINST STAPHYLOCOCCUS, STREPTOCOCCUS, MYCOBACTERIUM, AND CLOSTRIDIUM | PHARMACIA & UPJOHN COMPANY | 2001-11-06 | — | — | US | claimed |
| US-6051716-A | ANTIMICROBIAL AGENTS | PHARMACIA & UPJOHN, INC. (US) | 2000-04-18 | — | — | US | claimed |
| US-5929083-A | CONTAINING 3-AZABICYCLO(3.1.1)HEPTANE GROUPS | CHEIL JEDANG CORPORATION (KR) | 1999-07-27 | — | — | US | claimed |
| CN-1163892-A | 2-oxo-and 2-thio-1,2-dihydroquinolinyl-oxazolidinones | BAYER AG (DE) | 1997-11-05 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063117-A1 | Novel oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient | VRK1, ALPI, VRK2 | ALDH1A1 1099/4885NLRP3 504/4885LMNA 3682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.